CE
Healthcare & Life Sciences
Cellusion
Japancellusion.jp
Cellusion is a Healthcare & Life Sciences startup based in Japan, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About Cellusion
Cellusion is a startup based in Japan. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Cellusion develops regenerative medicine technologies using iPS cell-derived corneal endothelial cell substitutes to treat corneal endothelial diseases, aiming to address donor shortages and improve transplantation procedures globally.
Explore Cellusion's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.